Effects of verapamil on coronary vascular resistance in rabbits: Measurement with pulsed Doppler velocimetry

Chung Ben Kan, Chiao Po Hsu, Nai Wen Tsao, Shiau Ting Lai, Cheng Hsiung Huang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background. Verapamil is an effective vasodilator. The purpose of this study was to investigate the in vivo effect of verapamil on coronary blood flow velocity and vascular resistance in anesthetized, open-chest rabbits. Methods. Twenty-one male New Zealand white rabbits were anesthetized, and a 3-mm suction-type pulsed Doppler velocimeter probe was applied to the proximal part of the left anterior descending coronary artery after median sternotomy. The rabbits received intravenous bolus infusion of 4 different doses of verapamil (0.01 mg/kg, n = 5; 0.1 mg/kg, n = 5; 1 mg/kg, n = 5, and 10 mg/kg, n = 6). The percent changes in coronary blood flow velocity and coronary vascular resistance were examined. Results. There was 10.0 ± 1.6% increase in coronary blood flow (CBF) and 12.5 ± 1.9% reduction in coronary vascular resistance (CVR) after infusion of 0.01 mg/kg of verapamil. The CBF increased 23.0 ± 9.5% and CVR decreased 24.2 ± 5.2% after infusion of 0.1 mg/kg of verapamil. Infusion of 1 mg/kg of verapamil induced 34.8 ± 10.5% increase in CBF and 32.6 ± 2.5% reduction in CVR. The CBF increased 41.1 ± 14.8% and CVR decreased 45.1 ± 5.4% after infusion of 10 mg/kg of verapamil. Conclusions. Compared with baseline condition, all doses of verapamil increased coronary blood flow velocity and decreased coronary vascular resistance significantly in anesthetized, open-chest rabbits.

Original languageEnglish
Pages (from-to)715-720
Number of pages6
JournalChinese Medical Journal (Taipei)
Volume64
Issue number12
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Rheology
Verapamil
Vascular Resistance
Rabbits
Blood Flow Velocity
Thorax
Sternotomy
Suction
Vasodilator Agents
Intravenous Infusions
Coronary Vessels

Keywords

  • Coronary vasodilatation
  • Pulsed doppler velocimetry
  • Verapamil

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of verapamil on coronary vascular resistance in rabbits : Measurement with pulsed Doppler velocimetry. / Kan, Chung Ben; Hsu, Chiao Po; Tsao, Nai Wen; Lai, Shiau Ting; Huang, Cheng Hsiung.

In: Chinese Medical Journal (Taipei), Vol. 64, No. 12, 2001, p. 715-720.

Research output: Contribution to journalArticle

Kan, Chung Ben ; Hsu, Chiao Po ; Tsao, Nai Wen ; Lai, Shiau Ting ; Huang, Cheng Hsiung. / Effects of verapamil on coronary vascular resistance in rabbits : Measurement with pulsed Doppler velocimetry. In: Chinese Medical Journal (Taipei). 2001 ; Vol. 64, No. 12. pp. 715-720.
@article{ae92ba3cf1264d179676c6180cc578ff,
title = "Effects of verapamil on coronary vascular resistance in rabbits: Measurement with pulsed Doppler velocimetry",
abstract = "Background. Verapamil is an effective vasodilator. The purpose of this study was to investigate the in vivo effect of verapamil on coronary blood flow velocity and vascular resistance in anesthetized, open-chest rabbits. Methods. Twenty-one male New Zealand white rabbits were anesthetized, and a 3-mm suction-type pulsed Doppler velocimeter probe was applied to the proximal part of the left anterior descending coronary artery after median sternotomy. The rabbits received intravenous bolus infusion of 4 different doses of verapamil (0.01 mg/kg, n = 5; 0.1 mg/kg, n = 5; 1 mg/kg, n = 5, and 10 mg/kg, n = 6). The percent changes in coronary blood flow velocity and coronary vascular resistance were examined. Results. There was 10.0 ± 1.6{\%} increase in coronary blood flow (CBF) and 12.5 ± 1.9{\%} reduction in coronary vascular resistance (CVR) after infusion of 0.01 mg/kg of verapamil. The CBF increased 23.0 ± 9.5{\%} and CVR decreased 24.2 ± 5.2{\%} after infusion of 0.1 mg/kg of verapamil. Infusion of 1 mg/kg of verapamil induced 34.8 ± 10.5{\%} increase in CBF and 32.6 ± 2.5{\%} reduction in CVR. The CBF increased 41.1 ± 14.8{\%} and CVR decreased 45.1 ± 5.4{\%} after infusion of 10 mg/kg of verapamil. Conclusions. Compared with baseline condition, all doses of verapamil increased coronary blood flow velocity and decreased coronary vascular resistance significantly in anesthetized, open-chest rabbits.",
keywords = "Coronary vasodilatation, Pulsed doppler velocimetry, Verapamil",
author = "Kan, {Chung Ben} and Hsu, {Chiao Po} and Tsao, {Nai Wen} and Lai, {Shiau Ting} and Huang, {Cheng Hsiung}",
year = "2001",
language = "English",
volume = "64",
pages = "715--720",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "12",

}

TY - JOUR

T1 - Effects of verapamil on coronary vascular resistance in rabbits

T2 - Measurement with pulsed Doppler velocimetry

AU - Kan, Chung Ben

AU - Hsu, Chiao Po

AU - Tsao, Nai Wen

AU - Lai, Shiau Ting

AU - Huang, Cheng Hsiung

PY - 2001

Y1 - 2001

N2 - Background. Verapamil is an effective vasodilator. The purpose of this study was to investigate the in vivo effect of verapamil on coronary blood flow velocity and vascular resistance in anesthetized, open-chest rabbits. Methods. Twenty-one male New Zealand white rabbits were anesthetized, and a 3-mm suction-type pulsed Doppler velocimeter probe was applied to the proximal part of the left anterior descending coronary artery after median sternotomy. The rabbits received intravenous bolus infusion of 4 different doses of verapamil (0.01 mg/kg, n = 5; 0.1 mg/kg, n = 5; 1 mg/kg, n = 5, and 10 mg/kg, n = 6). The percent changes in coronary blood flow velocity and coronary vascular resistance were examined. Results. There was 10.0 ± 1.6% increase in coronary blood flow (CBF) and 12.5 ± 1.9% reduction in coronary vascular resistance (CVR) after infusion of 0.01 mg/kg of verapamil. The CBF increased 23.0 ± 9.5% and CVR decreased 24.2 ± 5.2% after infusion of 0.1 mg/kg of verapamil. Infusion of 1 mg/kg of verapamil induced 34.8 ± 10.5% increase in CBF and 32.6 ± 2.5% reduction in CVR. The CBF increased 41.1 ± 14.8% and CVR decreased 45.1 ± 5.4% after infusion of 10 mg/kg of verapamil. Conclusions. Compared with baseline condition, all doses of verapamil increased coronary blood flow velocity and decreased coronary vascular resistance significantly in anesthetized, open-chest rabbits.

AB - Background. Verapamil is an effective vasodilator. The purpose of this study was to investigate the in vivo effect of verapamil on coronary blood flow velocity and vascular resistance in anesthetized, open-chest rabbits. Methods. Twenty-one male New Zealand white rabbits were anesthetized, and a 3-mm suction-type pulsed Doppler velocimeter probe was applied to the proximal part of the left anterior descending coronary artery after median sternotomy. The rabbits received intravenous bolus infusion of 4 different doses of verapamil (0.01 mg/kg, n = 5; 0.1 mg/kg, n = 5; 1 mg/kg, n = 5, and 10 mg/kg, n = 6). The percent changes in coronary blood flow velocity and coronary vascular resistance were examined. Results. There was 10.0 ± 1.6% increase in coronary blood flow (CBF) and 12.5 ± 1.9% reduction in coronary vascular resistance (CVR) after infusion of 0.01 mg/kg of verapamil. The CBF increased 23.0 ± 9.5% and CVR decreased 24.2 ± 5.2% after infusion of 0.1 mg/kg of verapamil. Infusion of 1 mg/kg of verapamil induced 34.8 ± 10.5% increase in CBF and 32.6 ± 2.5% reduction in CVR. The CBF increased 41.1 ± 14.8% and CVR decreased 45.1 ± 5.4% after infusion of 10 mg/kg of verapamil. Conclusions. Compared with baseline condition, all doses of verapamil increased coronary blood flow velocity and decreased coronary vascular resistance significantly in anesthetized, open-chest rabbits.

KW - Coronary vasodilatation

KW - Pulsed doppler velocimetry

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0035727028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035727028&partnerID=8YFLogxK

M3 - Article

C2 - 11922492

AN - SCOPUS:0035727028

VL - 64

SP - 715

EP - 720

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 12

ER -